Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,074,058
New position
Shares Held
15,564
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#146
of 302 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIH Partners, LLLP holds $6,284,375 across 7 Biotechnology names. ABVX ranks #2 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
30,844 | $2,160,005 | |
| 2 | ABVX |
Abivax S.A.
This page
|
15,564 | $2,074,058 | |
| 3 | ARGX |
Argenx SE
|
1,418 | $1,315,577 | |
| 4 | BNTX |
BioNTech SE
|
5,300 | $493,165 | |
| 5 | ABSI |
Absci Corp
|
10,925 | $126,620 | |
| 6 | CGEN |
Compugen Ltd
|
42,585 | $91,131 | |
| 7 | AUTL |
Autolus Therapeutics plc
|
14,887 | $23,819 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,074,058 | 15,564 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||